Cargando…

Correction: Perifosine and CCI 779 Co-Operate to Induce Cell Death and Decrease Proliferation in PTEN-Intact and PTEN-Deficient PDGF-Driven Murine Glioblastoma

Detalles Bibliográficos
Autores principales:	Pitter, Kenneth L., Galbán, Craig J., Galbán, Stefanie, Tehrani, Omid Saeed, Li, Fei, Charles, Nikki, Bradbury, Michelle S., Becher, Oren J., Chenevert, Thomas L., Rehemtulla, Alnawaz, Ross, Brian D., Holland, Eric C., Hambardzumyan, Dolores
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3031634/ http://dx.doi.org/10.1371/annotation/66641ad6-afb9-4d3c-ade6-73fcd5aab061

Ejemplares similares

Perifosine and CCI 779 Co-Operate to Induce Cell Death and Decrease Proliferation in PTEN-Intact and PTEN-Deficient PDGF-Driven Murine Glioblastoma
por: Pitter, Kenneth L., et al.
Publicado: (2011)

Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779
por: Messina, Michael P, et al.
Publicado: (2007)

The Rapalogue, CCI-779, Improves Salivary Gland Function following Radiation
por: Morgan-Bathke, Maria, et al.
Publicado: (2014)

Evaluation of Concurrent Radiation, Temozolomide and ABT-888 Treatment Followed by Maintenance Therapy with Temozolomide and ABT-888 in a Genetically Engineered Glioblastoma Mouse Model
por: Lemasson, Benjamin, et al.
Publicado: (2016)

DW-MRI as a Biomarker to Compare Therapeutic Outcomes in Radiotherapy Regimens Incorporating Temozolomide or Gemcitabine in Glioblastoma
por: Galbán, Stefanie, et al.
Publicado: (2012)

Heterozygosity for Pten Promotes Tumorigenesis in a Mouse Model of Medulloblastoma
por: Castellino, Robert C., et al.
Publicado: (2010)

The uterine epithelial loss of Pten is inefficient to induce endometrial cancer with intact stromal Pten
por: Liang, Xiaohuan, et al.
Publicado: (2018)

Lung cancer lesion detection in histopathology images using graph‐based sparse PCA network()
por: Ram, Sundaresh, et al.
Publicado: (2023)

Integrated Multimodal Imaging of Dynamic Bone-Tumor Alterations Associated with Metastatic Prostate Cancer
por: Brisset, Jean-Christophe, et al.
Publicado: (2015)

CT-based Biomarker Provides Unique Signature for Diagnosis of COPD Phenotypes and Disease Progression
por: Galbán, Craig J., et al.
Publicado: (2012)

The novel mTOR inhibitor CCI-779 (temsirolimus) induces antiproliferative effects through inhibition of mTOR in Bel-7402 liver cancer cells
por: Li, Shuyu, et al.
Publicado: (2013)

CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab
por: Niehr, Franziska, et al.
Publicado: (2015)

The adapter protein FADD provides an alternate pathway for entry into the cell cycle by regulating APC/C-Cdh1 E3 ubiquitin ligase activity
por: Awadia, Sahezeel, et al.
Publicado: (2023)

阿帕替尼联合CCI-779体外抑制小细胞肺癌细胞株NCI-H446的增殖和迁移
Publicado: (2020)

The Probable Cell of Origin of NF1- and PDGF-Driven Glioblastomas
por: Hambardzumyan, Dolores, et al.
Publicado: (2011)

Catalysis by the Tumor-Suppressor Enzymes PTEN and PTEN-L
por: Johnston, Sean B., et al.
Publicado: (2015)

Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma
por: Kaley, Thomas J., et al.
Publicado: (2020)

Sorafenib induces cathepsin B-mediated apoptosis of bladder cancer cells by regulating the Akt/PTEN pathway. The Akt inhibitor, perifosine, enhances the sorafenib-induced cytotoxicity against bladder cancer cells
por: Amantini, Consuelo, et al.
Publicado: (2015)

The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer
por: Turnham, Daniel J., et al.
Publicado: (2020)

The perfect PTEN – transcriptional regulation by PTEN dictates sarcoma identity
por: Langdon, Casey G., et al.
Publicado: (2021)

PTEN Redundancy: Overexpressing lpten, a Homolog of Dictyostelium discoideum ptenA, the Ortholog of Human PTEN, Rescues All Behavioral Defects of the Mutant ptenA(−)
por: Lusche, Daniel F., et al.
Publicado: (2014)

Multi-Site Clinical Evaluation of DW-MRI as a Treatment Response Metric for Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
por: Galbán, Craig J., et al.
Publicado: (2015)

PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort
por: Lotan, Tamara L., et al.
Publicado: (2017)

In renal cell carcinoma the PTEN splice variant PTEN-Δ shows similar function as the tumor suppressor PTEN itself
por: Breuksch, Ines, et al.
Publicado: (2018)

Imaging Proteolytic Activities in Mouse Models of Cancer
por: Pal, Anupama, et al.
Publicado: (2018)

Semiautomated Workflow for Clinically Streamlined Glioma Parametric Response Mapping
por: Keith, Lauren, et al.
Publicado: (2016)

PTEN haploinsufficiency and hemangiosarcoma
Publicado: (2012)

Focus on PTEN Regulation
por: Bermúdez Brito, Miriam, et al.
Publicado: (2015)

Pten in mouse vagina
por: Miyagawa, Shinichi, et al.
Publicado: (2015)

PTEN and Gynecological Cancers
por: Nero, Camilla, et al.
Publicado: (2019)

A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors
por: Becher, Oren J., et al.
Publicado: (2017)

Genome-wide identification of genetic determinants for the cytotoxicity of perifosine
por: Zhang, Wei, et al.
Publicado: (2008)

Perifosine as a potential novel anti-telomerase therapy
por: Holohan, Brody, et al.
Publicado: (2015)

Poly-ADP ribosylation of PTEN by tankyrases promotes PTEN degradation and tumor growth
por: Li, Nan, et al.
Publicado: (2015)

PTENβ is an alternatively translated isoform of PTEN that regulates rDNA transcription
por: Liang, Hui, et al.
Publicado: (2017)

Astrocyte-Specific Expression Patterns Associated with the PDGF-Induced Glioma Microenvironment
por: Katz, Amanda M., et al.
Publicado: (2012)

Lack of PTEN in osteocytes increases circulating phosphate concentrations by decreasing intact fibroblast growth factor 23 levels
por: Kawai, Masanobu, et al.
Publicado: (2020)

PTENα functions as an immune suppressor and promotes immune resistance in PTEN-mutant cancer
por: Sun, Yizhe, et al.
Publicado: (2021)

circPTEN suppresses colorectal cancer progression through regulating PTEN/AKT pathway
por: Li, Chen, et al.
Publicado: (2021)

Emerging treatment options for the treatment of neuroblastoma: potential role of perifosine
por: Sun, Weili, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_9ud4kkg86bplhc32j65nif1ue8